Overview
- IndustryRetail-Drug Stores and Proprietary Stores2
- HeadquartersNew York, United States2
- Incorporated inCO3
- Business addressHongxing Intl Business Building 2,, 14Th Flr, No. 69, Qingyun Souve Ave.,, Jinjiang District,Chengdu City, F4 6100213
- Filer category, Emerging growth company3
- Legal formProfit Corporation2
- LEI549300XIW90IX3IR41402
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O CSC Services of Nevada, Inc., 89119 Las Vegas, United States2
- Registered withBusiness Center (Secretary of State), E0339632017-62
See how the biggest companies compare on our leaderboards
September 2021 we completed the acquisition of nine pharmacies located in Chengdu. We currently operate pharmacies at eight locations.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue58¢$867.8K
- Other costs40¢$602.6K
- Interest1¢$18.6K
- Income tax0¢$391
Out of $1.5M in revenue.5 The company lost money this year.
Financial statements
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $3.4M6 | $2.5M7 | $3.1M8 | $2.7M9 | $4.1M10 | $3.8M5 | $1.5M5 |
| Cost of revenue | $388.9K6 | $224.7K6 | $1.6M10 | $1.8M5 | $867.8K5 | ||
| Gross profit | $3.0M6 | $2.2M6 | |||||
| Operating expenses | $3.1M8 | $5.3M9 | $6.6M9 | ||||
| Operating income | $759.9K6 | $794.5K7 | -$26.9K8 | -$2.6M9 | -$2.5M10 | -$2.6M5 | -$2.5M5 |
| Interest | $77.2K5 | $18.6K5 | |||||
| Income before tax | $7.1K8 | -$6.4M9 | -$2.1M10 | -$2.8M5 | -$2.0M5 | ||
| Income tax | $340.1K7 | $274.3K8 | $1.1K9 | $19.5K10 | $5285 | $3915 | |
| Net income | $1.9M6 | $1.0M7 | -$267.2K8 | -$6.4M9 | -$2.1M10 | -$2.8M5 | -$2.0M5 |
| Earnings per share | -$0.018 | -$0.269 | -$0.0810 | -$0.115 | -$0.085 | ||
| Earnings per share (diluted) | -$0.269 | -$0.0810 | -$0.115 | -$0.085 | |||
| Shares (weighted, basic) | 25.0M shares8 | 25.0M shares9 | 25.0M shares10 | 25.0M shares5 | 25.0M shares5 | ||
| Shares (weighted, diluted) | 25.0M shares9 | 25.0M shares10 | 25.0M shares5 | 25.0M shares5 |
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash | $9.8K6 | $7.7M7 | $8.6M8 | $510.1K9 | $443.8K10 | $62.3K5 | $20.8K5 |
| Receivables | $45.9K8 | $562.6K9 | $253.6K9 | ||||
| Inventory | $233.5K8 | $499.3K9 | $441.1K10 | $504.0K5 | $427.4K5 | ||
| Current assets | $5.7M6 | $7.9M7 | $9.2M8 | $2.0M9 | $1.5M10 | $1.5M5 | $1.0M5 |
| Property, plant and equipment | $290.1K8 | $2.0M9 | $1.7M10 | $1.5M5 | $660.2K5 | ||
| Intangible assets | $1.9K8 | $1.3K9 | $3.9K10 | $4.5K5 | $2.8K5 | ||
| Total assets | $6.1M6 | $8.1M7 | $11.7M8 | $5.1M9 | $4.8M10 | $4.4M5 | $3.2M5 |
| Accounts payable | $406.2K8 | $398.5K8 | |||||
| Short-term debt | $85.8K5 | ||||||
| Current liabilities | $927.7K6 | $1.2M7 | $4.5M8 | $5.3M9 | $6.0M10 | $7.5M5 | $8.5M5 |
| Total liabilities | $995.2K6 | $1.2M7 | $5.6M8 | $5.5M9 | $6.8M10 | $8.7M5 | $9.8M5 |
| Retained earnings | -$8.9M8 | -$15.2M9 | -$17.2M10 | -$20.0M5 | -$22.0M5 | ||
| Shareholders’ equity | $5.1M7 | $6.9M8 | $6.1M9 | -$466.2K10 | -$1.9M5 | -$4.3M5 | -$6.6M5 |
| Shares outstanding | 85.0M shares6 | 50.0M shares7 | 25.0M shares8 | 25.0M shares9 | 25.0M shares10 | 25.0M shares5 | 25.0M shares5 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -$1.0M6 | $1.6M7 | -$57.8K8 | -$1.6M9 | -$1.4M10 | -$1.6M5 | -$2.0M5 |
| Depreciation and amortization | $96.1K8 | $185.6K9 | $410.7K10 | $321.3K5 | $156.8K5 | ||
| Stock-based compensation | $371.5K8 | $371.5K9 | $371.5K10 | $301.1K5 | |||
| Capital spending | $57.9K6 | $2.2K7 | $1.3K8 | $156.7K9 | $295.5K10 | $241.7K5 | $13.0K5 |
| Free cash flow | -$1.1M | $1.6M | -$59.1K | -$1.8M | -$1.7M | -$1.9M | -$2.0M |
| Cash from investing | -$4.4M8 | -$3.5M9 | -$302.8K10 | -$195.2K5 | -$13.0K5 | ||
| Cash from financing | $5.2M8 | -$2.4M9 | $1.6M10 | $1.4M5 | $2.0M5 |
Corporate structure
AiXin Life International, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of AiXin Life International, Inc.
- Quanzhong Lin Filed SC 13D on AiXin Life International, Inc., latest Feb 13, 2023
- Yao-Te Wang Filed SC 13D on AiXin Life International, Inc., latest Feb 13, 2023
- AiXin Life International, Inc. New York, New York, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What AiXin Life International, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $2.1M5 Dec 31, 2025 | $3.1M5 Dec 31, 2024 | −32.7% |
| Accumulated depreciation | $1.4M5 Dec 31, 2025 | $1.6M5 Dec 31, 2024 | −11.1% |
| Property and equipment, net | $660.2K5 Dec 31, 2025 | $1.5M5 Dec 31, 2024 | −55.8% |
| Operating-lease assets (leased space) | $1.5M5 Dec 31, 2025 | $1.5M5 Dec 31, 2024 | +4.8% |
Investments
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Intangible assets, net (excluding goodwill) | $2.8K5 Dec 31, 2025 | $4.5K5 Dec 31, 2024 | −38.3% |
| Finite-lived intangibles, gross | $5.3K5 Dec 31, 2025 | $5.9K5 Dec 31, 2024 | −11.3% |
| Accumulated amortization | $2.5K5 Dec 31, 2025 | $1.4K5 Dec 31, 2024 | +75.4% |
| Finite-lived intangibles, net | $2.8K5 Dec 31, 2025 | $4.5K5 Dec 31, 2024 | −38.3% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $427.4K5 Dec 31, 2025 | $504.0K5 Dec 31, 2024 | −15.2% |
| Raw materials | $150.0K5 Dec 31, 2025 | $260.0K5 Dec 31, 2024 | −42.3% |
Properties, in its own words
All of our pharmacies operate at locations leased from a third party pursuant to a short term lease at a market rate rent. In addition to the pharmacies, we maintain our administrative offices in leased remises in Chengdu.
Yunnan Runcangsheng operates a 2,946 square meter production facility, including, R&D centers, extraction facilities, preparation workshops and a warehouse. Yunnan Runcangsheng operates planting facilities where it grows some of the key ingredients used in its products. In November 2025 the Company entered into a three year lease for this property at an annual rent of $44,720.
The rest of Item 2
The term of our lease with respect to our hotel located in Bandzhuyuan Town, Xindu District, Chengdu City, commenced February 29, 2024 and expires April 15, 2034. The lease grants us the right to occupy various areas within the hotel, covering approximately 18,000 square meters, including the first-floor lobby, external shops (subject to the rights of the current occupants), second to fourth floors, fifth to eighteenth floors (inclusive of meeting rooms and part of the dining rooms), underground and ground-level parking lots, and all hotel facilities and equipment.
Item 2 of the 10-K filed May 15, 2026.4
Leadership
Who has led AiXin Life International, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerQuanzhong Lin Jul 12, 2018 to Jul 12, 201813
- Chief executive officerScott L. Mathis Nov 12, 2009 to Jan 23, 201714
- PresidentQuanzhong Lin Jul 12, 2018 to Jul 12, 201813
- PresidentScott L. Mathis Nov 12, 2009 to Jan 23, 201714
- PresidentRobert Marsik Mar 26, 2007 to Mar 26, 200715
- PresidentLawrence M. Underwood Jun 18, 2007 to Nov 10, 200916
- Chief financial officerXiaowen Zheng Jan 21, 2025 to Jan 21, 202517
- Chief financial officerGuolu Li Jul 10, 2018 to Jul 10, 201818
- Chief financial officerMaria I. Echevarria Apr 17, 2015 to Jan 23, 201719
- Chief financial officerTim F. Holderbaum Nov 12, 2009 to Nov 12, 200920
- Chief operating officerRonald S. Robbins Nov 12, 2009 to Nov 12, 200921
Board members and other officers (12)
- Secretary/TreasurerJohn Patrick Kanouff Jun 18, 2007 to Nov 10, 200922
- Board memberHsin-Liang Christopher Lee Jan 24, 2023 to Jan 24, 202323
- Board memberQuanzhong Lin Jul 12, 2018 to Jul 12, 201813
- Board memberYao-Te Wang Jul 12, 2018 to Jul 12, 201824
- Board memberJulian Beale Nov 12, 2009 to Nov 12, 200925
- Board memberPeter J.l. Lawrence Nov 12, 2009 to Jan 23, 201726
- Board memberScott L. Mathis Nov 12, 2009 to Jan 23, 201714
- Board memberRobert Marsik Mar 26, 2007 to Mar 26, 200715
- Board memberAllan Bergenfield Apr 16, 2007 to Apr 16, 200727
- Board memberThomas A. Higgins May 4, 2007 to May 4, 200728
- Board memberJohn Patrick Kanouff Jun 18, 2007 to Nov 10, 200922
- Board memberLawrence M. Underwood Jun 18, 2007 to Nov 10, 200916
Former names
- MERCARI COMMUNICATIONS GROUP LTDMar 4, 2002 to Feb 1, 20183
Timeline
- May 18, 20268-K Executive or director change29
- Apr 16, 20268-K Executive or director change30
- Jan 28, 20268-K Executive or director change31
- Apr 10, 20258-K Earlier financial statements no longer reliable32
- Mar 25, 20258-K Earlier financial statements no longer reliable33
- Mar 24, 20258-K Earlier financial statements no longer reliable34
- Feb 13, 20258-K Change of auditor35
- Jan 13, 20258-K Change of auditor36
- Jan 10, 20258-K Executive or director change37
- Apr 25, 20238-K Listing notice or transfer38
- Apr 17, 20238-K Results of operations39
- Feb 15, 20238-K Bylaws or fiscal year changed40
- Jul 12, 2018New chief executive Quanzhong Lin becomes CEO13
- Nov 12, 2009New chief executive Scott L. Mathis becomes CEO14
Calendar
When it reported results
- Apr 17, 2023Reported quarterly or annual results39
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
76 filings to the SEC since October 2021: 5 annual reports, 13 quarterly reports, 21 major events, 2 insider forms, 2 large holders, 33 other. The latest 20:
- May 18, 20268-K EDGAR
- May 18, 2026NT 10-Q EDGAR
- May 15, 202610-K EDGAR
- May 7, 2026RW EDGAR
- Apr 16, 20268-K EDGAR
- Apr 2, 2026NT 10-K EDGAR
- Jan 28, 20268-K EDGAR
- Nov 19, 202510-Q EDGAR
- Nov 17, 2025NT 10-Q EDGAR
- Aug 20, 202510-Q EDGAR
- Aug 15, 2025NT 10-Q EDGAR
- Jun 27, 202510-Q EDGAR
- May 19, 2025NT 10-Q EDGAR
- May 7, 202510-K EDGAR
- Apr 15, 2025S-1/A EDGAR
- Apr 10, 20258-K/A EDGAR
- Apr 1, 2025NT 10-K EDGAR
- Mar 25, 20258-K EDGAR
- Mar 24, 20258-K EDGAR
- Feb 13, 20258-K EDGAR
The 76 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Quanzhong LinSC 13D, 1 filing Feb 13, 202341
- Yao-Te WangSC 13D, 1 filing Feb 13, 202342
SEC filer profile
How AiXin Life International, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARAiXin Life International, Inc.1
- CIK0000835662
- Employer ID (EIN)84-10859354
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company4
- Incorporated inColorado4
- Fiscal year endsDecember 311
- Industry code (SIC)5912 Retail-Drug Stores and Proprietary Stores1
- SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
- Business addressHongxing Intl Business Building 2,, 14Th Flr, No. 69, Qingyun Souve Ave.,, Jinjiang District,Chengdu City, F4 6100211
- Phone212-739-76891
- Shares outstanding24,999,834 shares as of May 12, 20264
- Public float$883.7K as of Jun 30, 20254
- AuditorYCM CPA INC, Irvine, California PCAOB ID 6781; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceMar 4, 20021
- Filings294 in all: 8-K (54), 10-Q (53), 10QSB (21), 4 (20), 10-K (18), NT 10-Q (18), 3 (14), 8-K/A (12)1
All 29 form types
NT 10-K (12), 10KSB (8), S-1/A (8), 10QSB/A (6), DEF 14C (6), SC 13D/A (6), UPLOAD (6), CORRESP (5), PRE 14C (5), SC 13D (5), DEF 14A (4), SC 14F1 (3), PRE 14A (2), 10-K/A (1), 10-Q/A (1), NT 10-Q/A (1), NTN 10K (1), PRER14A (1), RW (1), S-1 (1), S-8 (1)
- Latest filingsAnnual report (10-K) May 15, 2026
Quarterly report (10-Q) Nov 19, 2025
Proxy statement (DEF 14A) Dec 19, 2022
Latest 8-K (8-K) May 18, 2026
Risk factors and legal proceedings
The risks AiXin Life International, Inc. names in Item 1A of its 10-K filed May 15, 2026: 66 risks under these headings, as written.4
- Risks Associated with Our Company
- We incurred net losses in 2025 and 2024 and may not be able to continue to operate as a going concern.
- We operate in a highly competitive industry and our failure to compete effectively could adversely affect our market share, revenues and growth prospects.
- We have a limited operating history on which to judge our performance and assess our prospects for future success.
- Our acquisition of Yunnan Runcangsheng is subject to uncertainties and risks.
- Our future expansion plans are subject to uncertainties and risks.
- Failure to effectively anticipate consumer preferences could negatively impact the demand for our products and our ability to generate revenues and the market price of our common stock.
- Resources devoted to product innovation may not yield new products that achieve commercial success.
- If we do not successfully develop and maintain a robust omni-channel experience for our customers, our business and results of operations could be materially and adversely affected.
- The operation of our hotel is subject to the business, financial and operating risks inherent to the hospitality industry, any of which could reduce the revenues derived at our hotel.
- We may incur material product liability claims, or experience product recalls, which could increase our costs and adversely affect our sales and margin, reputation, revenues and operating income.
- If we fail to develop and protect our brand names and reputation, we may not attract and retain new customers, which could adversely affect our revenues and financial performance.
The other 55 risks
- Our ability to adequately protect our trade names and trademarks could have an impact on our brand images and ability to penetrate new markets.
- Unfavourable publicity about us or consumer perception of our products, , including the nutritional supplements we distribute, the ingredients they contain and any similar products distributed by other companies could cause fluctuations in our operating results and could have a material adverse effect on our reputation, the demand for our products and our ability to generate revenues and the market price of our common stock.
- We may be subject to health or advertising claims related to our customers.
- We rely on third parties to provide us with nutritional supplements, fulfillment, customer service and Internet and networking services, the loss of any of which could cause our revenue, earnings or reputation to suffer.
- We depend on the services of key executives and other skilled professionals and our ability to attract, train and retain highly qualified associates. Any failure to attract or retain such individuals could affect our business strategy and adversely impact our performance and results of operations.
- Compliance with new and existing laws and governmental regulations could increase our costs significantly and adversely affect our results of operations.
- We depend upon a limited number of suppliers for certain raw materials and any disruption to our timely receipt of raw materials and inventory could adversely impact sales and operations or increase our transportation costs, which would decrease our profits.
- Natural disasters (whether or not caused by climate change), unusually adverse weather conditions, pandemic outbreaks and terrorist acts in China and the response of the Chinese governments to such occurrences, could impair our ability to purchase, receive or replenish inventory or raw materials or cause customer traffic to decline, all of which could result in lost sales and otherwise adversely affect our financial performance.
- We rely on third parties for the vast majority of our computing, storage, and other services related to our business. Any disruption of or interference with our use of the services of these third parties would negatively affect our operations and could seriously harm our business.
- As we increase the amount of personal and user data we store and process, we may become subject to complex and evolving laws, regulations, executive actions, rules, contractual obligations, policies, and other obligations regarding privacy, data protection, content, and other matters. Many of these obligations are subject to change and uncertain interpretations.
- Cyber attacks could have a disruptive effect on our business.
- Our business and our ability to raise capital may be materially adversely affected by global geopolitical conditions resulting from the ongoing Russia-Ukraine conflict, the Israel-Hamas conflict, the conflict in Iran and the disruption in the oil markets, and other recent actions undertaken by the United States, such as the imposition of tariffs and the response of China and other nations thereto.
- We may be impacted by our ability to attract, develop and retain qualified associates and manage labor-related costs.
- Our insurance may not be sufficient.
- Our business depends on the continued contributions made by Mr. Quanzhong Lin, our key executive officer. The loss of his services may result in a severe impediment to our business.
- Should Mr. Lin fail to obtain conclusive written evidence from the local authorities stating that the criminal investigation against him has been terminated, he may be forced to resign from his positions in the Company.
- Our key executive does not devote his full business time to our operations.
- Our principal shareholder is not familiar with American business practices.
- We may be adversely impacted by certain compliance or legal matters.
- Failure to make adequate contributions to various employee benefits plans as required by PRC regulations may subject us to penalties.
- Our common stock may be delisted under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect our auditors. The delisting of our common stock or the threat of their being delisted, may materially and adversely affect the value of your investment.
- A joint statement by the SEC and the Public Company Accounting Oversight Board (United States), or the “PCAOB,” the newly enacted “Holding Foreign Companies Accountable Act” and the “Accelerating Holding Foreign Companies Accountable Act” all call for additional and more stringent criteria to be applied to emerging market companies upon assessing the qualification of their auditors, especially the non-U.S. auditors who are not inspected by the PCAOB. These developments could add uncertainties to the market for our common stock.
- There are uncertainties under the PRC Securities Law relating to the procedures and requisite timing for the U.S. securities regulatory agencies to conduct investigations and collect evidence within the territory of the PRC.
- We could be subject to conflicting demands placed upon us by regulatory authorities in the United States and the PRC which could result in disciplinary actions if not resolved.
- We are exposed to liabilities relating to environmental protection and safety laws and regulations.
- We require additional financing and our operations could be curtailed if we are unable to obtain required additional financing when needed.
- General Risks Associated with Business Operations in China
- The PRC government has significant oversight and discretion over the conduct of a PRC company’s business operations or to exert control over any offering of securities conducted overseas and/or foreign investment in China-based issuers, and may intervene with or influence our operations, may limit or completely hinder our ability to offer or continue to offer securities to investors, and may cause the value of such securities to significantly decline or become worthless, as the government deems appropriate to further regulatory, political and societal goals.
- The CSRC has released draft rules for China-based companies seeking to conduct initial public offerings in foreign markets. The Chinese government may exert more oversight and control over offerings that are conducted overseas and foreign investment in China-based issuers, which could significantly limit or completely hinder our ability to offer or continue to offer our common stock to investors and could cause the value of our common stock to significantly decline or become worthless.
- The CSRC has released the Trial Measures requiring Chinese domestic companies to complete filings with the CSRC if they complete an overseas offering and listing of their securities.
- The CSRC has released Provisions on Strengthening the Confidentiality and Archives Administration Related to the Overseas Securities Offering and Listing by Domestic Enterprises which may limit the activities of or disclosures made by companies in the PRC which, directly or indirectly, list their securities overseas.
- You may have difficulty in effecting service of legal process or bringing actions in China against us or our management based on foreign laws.
- You may have difficulty in enforcing foreign judgements in China against us or our management.
- Foreign exchange fluctuations may affect our business.
- Inflation could pose a risk to our business.
- Changes in the policies, regulations, rules and the enforcement of laws of the PRC government may be quick with little advance notice and could have a significant impact upon the business we may be able to conduct in the PRC and the profitability of such business.
- There are uncertainties regarding the interpretation and enforcement of PRC laws, rules and regulations.
- PRC regulations regarding acquisitions impose significant regulatory approval and review requirements, which could make it more difficult for us to pursue growth through acquisitions.
- Our business may be subject to a variety of PRC laws and other obligations regarding cybersecurity and data protection.
- PRC regulations relating to investments in offshore companies by PRC residents may subject our PRC-resident beneficial owners or our PRC Subsidiaries to liability or penalties, limit our ability to inject capital into our PRC Subsidiaries or limit our PRC Subsidiaries’ ability to increase their registered capital or distribute profits.
- We may be treated as a resident enterprise for PRC tax purposes under the PRC Enterprise Income Tax Law, and we may therefore be subject to PRC income tax on our global income.
- Restrictions on currency exchange may limit our ability to utilize our PRC revenue effectively.
- Fluctuations in foreign exchange rates will impact our reported results.
- The disclosures in our reports and other filings with the SEC and our other public pronouncements are not subject to the scrutiny of any regulatory bodies in the PRC.
- Introduction of new laws or changes to existing laws by the PRC government may adversely affect our business.
- Risks Relating to Our Holding Company Structure
- Substantial uncertainties exist with respect to the interpretation and implementation of the newly enacted Foreign Investment Law and how it may impact the viability of our current corporate structure, corporate governance and business operations.
- We may rely on dividends and other distributions on equity paid by our PRC Subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC Subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business.
- PRC regulation of loans to and direct investment in PRC entities by offshore holding companies and governmental control of currency conversion may delay or prevent us from making loans or additional capital contributions to our PRC Subsidiaries, which could materially and adversely affect our liquidity and our ability to fund and expand our business.
- Risks Related to our Common Stock
- There is a limited public market for our common stock and you may not be able to resell our shares at or above the price you paid or at all.
- The market price of our shares is likely to be highly volatile, which could result in substantial losses to investors.
- Military or other conflicts in Ukraine, the Middle East, Iran or elsewhere and increased geopolitical tensions may lead to increased volume and price volatility for publicly traded securities which could adversely impact the price of our common stock.
- The sale or availability for sale of substantial amounts of our common stock could adversely affect its market price.
- If securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations regarding our common stock, the market price for our common stock and trading volume could decline.
- Because we do not expect to pay dividends in the foreseeable future, you must rely on price appreciation of our common stock for return on your investment.
- Our CEO has substantial influence over our company. His interests may not be aligned with the interests of our other shareholders, and he could prevent or cause a change of control or other transactions.
Legal proceedings
From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results.
In December 2020, Jian Yiao (the “Plaintiff”) filed a complaint against Chengdu Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”) in Zhangjiagang People’s Court in Jiangsu Province. The complaint alleges that Mr. Yiao is entitled to $392,305 (RMB2,500,000) from Aixintang Pharmacy for breaching a purchase agreement entered in March 2020 (the “Purchase Agreement”). Aixintang Pharmacy claimed that the Purchase Agreement was the result of a forgery by an employee, and that Aixintang Pharmacy did not enter the Purchase Agreement. The Court determined that Aixintang Pharmacy breached the Purchase Agreement by not delivering the products ordered and ordered Aixintang Pharmacy to pay $392,305 (RMB2,500,000) to the Plaintiff. In December 2020, Aixintang Pharmacy filed a motion in the Jiangsu Suzhou Intermediate People’s Court against the verdict.
In February 2021, the judge in the Jiangsu Suzhou Intermediate People’s Court denied Aixintang Pharmacy’s motion and upheld the judgment from the first trial. In March 2021, Aixintang Pharmacy filed another motion to the Jiangsu High People’s Court on the basis that the Purchase Agreement was forged. In February 2022, Aixintang Pharmacy filed an appeal in Jiangsu High People’s Court against the judgment reached by Jiangsu Suzhou Intermediate People’s Court in February 2021. In September 2022, the Court rejected the Defendant’s motion and upheld the judgment rendered in the second trial.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARRobert Marsik, President
- 16SEC EDGARLawrence M. Underwood, President
- 17
- 18SEC EDGARGuolu Li, Chief financial officer
- 19
- 20
- 21
- 22
- 23
- 24SEC EDGARYao-Te Wang, Board member
- 25SEC EDGARJulian Beale, Board member
- 26SEC EDGARPeter J.l. Lawrence, Board member
- 27SEC EDGARAllan Bergenfield, Board member
- 28SEC EDGARThomas A. Higgins, Board member
- 29SEC EDGARExecutive or director change
- 30SEC EDGARExecutive or director change
- 31SEC EDGARExecutive or director change
- 32
- 33
- 34
- 35SEC EDGARChange of auditor
- 36SEC EDGARChange of auditor
- 37SEC EDGARExecutive or director change
- 38SEC EDGARListing notice or transfer
- 39SEC EDGARResults of operations
- 40SEC EDGARBylaws or fiscal year changed
- 41
- 42